Perrigo Total Assets 2006-2019 | PRGO

Perrigo total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Perrigo total assets for the quarter ending June 30, 2019 were $11.429B, a 1.81% increase year-over-year.
  • Perrigo total assets for 2018 were $10.983B, a 5.55% decline from 2017.
  • Perrigo total assets for 2017 were $11.629B, a 16.16% decline from 2016.
  • Perrigo total assets for 2016 were $13.87B, a 28.32% decline from 2015.
Perrigo Annual Total Assets
(Millions of US $)
2018 $10,983
2017 $11,629
2016 $13,870
2015 $19,350
2015 $19,592
2014 $13,853
2013 $5,351
2012 $4,024
2011 $3,189
2010 $3,109
2009 $2,443
2008 $2,578
2007 $1,925
2006 $1,751
2005 $1,705
Perrigo Quarterly Total Assets
(Millions of US $)
Q2 2019 $11,429
Q1 2019 $11,120
Q4 2018 $10,983
Q3 2018 $10,943
Q2 2018 $11,226
Q1 2018 $11,640
Q4 2017 $11,629
Q3 2017 $11,843
Q2 2017 $11,792
Q1 2017 $13,979
Q4 2016 $13,870
Q3 2016 $15,888
Q2 2016 $18,291
Q1 2016 $19,500
Q4 2015 $19,350
Q3 2015 $19,703
Q2 2015 $19,721
Q1 2015 $16,183
Q4 2014 $16,461
Q3 2014 $13,781
Q2 2014 $13,880
Q1 2014 $13,743
Q4 2013 $13,713
Q3 2013 $5,509
Q2 2013 $5,351
Q1 2013 $4,496
Q4 2012 $4,294
Q3 2012 $4,117
Q2 2012 $4,024
Q1 2012 $4,040
Q4 2011 $3,943
Q3 2011 $3,514
Q2 2011 $3,189
Q1 2011 $3,037
Q4 2010 $2,935
Q3 2010 $2,772
Q2 2010 $3,109
Q1 2010 $2,489
Q4 2009 $2,459
Q3 2009 $2,407
Q2 2009 $2,536
Q1 2009 $2,372
Q4 2008 $2,428
Q3 2008 $2,505
Q2 2008 $2,581
Q1 2008 $2,199
Q4 2007 $2,039
Q3 2007 $1,947
Q2 2007 $1,925
Q1 2007 $1,891
Q4 2006 $1,854
Q3 2006 $1,816
Q2 2006 $1,751
Q1 2006 $1,671
Q4 2005 $1,684
Q3 2005 $1,691
Q2 2005 $1,705
Q1 2005 $1,731
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $7.388B $4.732B
Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $148.939B 20.91
Abbott Laboratories (ABT) United States $147.101B 27.65
Stryker (SYK) United States $82.696B 28.60
Boston Scientific (BSX) United States $59.981B 29.09
Baxter (BAX) United States $44.653B 27.08
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.674B 18.35
Lonza Group Ag (LZAGY) Switzerland $25.863B 0.00
Coloplast (CLPBY) Denmark $25.834B 41.24
Terumo (TRUMY) Japan $23.226B 26.71
Smith & Nephew SNATS (SNN) United Kingdom $20.906B 0.00
ResMed (RMD) United States $19.182B 36.58
Sunny Optical Technology (SNPTF) China $16.804B 0.00
Bio-Rad Laboratories (BIO) United States $10.124B 54.27
Insulet (PODD) United States $9.197B 544.96
Canopy Growth (CGC) Canada $9.163B 0.00
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.984B 20.82
Haemonetics (HAE) United States $6.525B 49.24
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.265B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.167B 0.00
Neogen (NEOG) United States $4.002B 66.44
NuVasive (NUVA) United States $3.387B 27.00
ICU Medical (ICUI) United States $3.307B 21.45
Hutchison China MediTech (HCM) China $2.719B 0.00
Quidel (QDEL) United States $2.651B 26.33
Agios Pharmaceuticals (AGIO) United States $2.117B 0.00
National Vision Holdings (EYE) United States $2.015B 43.49
Cardiovascular Systems (CSII) United States $1.761B 0.00
Aphria (APHA) $1.519B 0.00
VAREX IMAGING (VREX) United States $1.090B 25.12
AtriCure (ATRC) United States $1.008B 0.00
Lantheus Holdings (LNTH) United States $1.003B 26.37
Omeros (OMER) United States $0.896B 0.00
Phibro Animal Health (PAHC) United States $0.881B 14.34
Eagle Pharmaceuticals (EGRX) United States $0.802B 20.45
NanoString Technologies (NSTG) United States $0.801B 0.00
Cerus (CERS) United States $0.745B 0.00
PetIQ (PETQ) United States $0.730B 17.25
LeMaitre Vascular (LMAT) United States $0.709B 42.01
MacroGenics (MGNX) United States $0.636B 0.00
Surmodics (SRDX) United States $0.620B 117.92
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.599B 0.00
OraSure Technologies (OSUR) United States $0.462B 21.40
Meridian Bioscience (VIVO) United States $0.407B 12.71
BioLife Solutions (BLFS) United States $0.396B 130.13
Utah Medical Products (UTMD) United States $0.368B 26.98
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.351B 0.00
Owens & Minor (OMI) United States $0.349B 10.47
Zynex (ZYXI) United States $0.315B 33.45
United Health Products (UEEC) United States $0.270B 0.00
Bovie Medical (APYX) United States $0.247B 0.00
Rockwell Medical (RMTI) United States $0.207B 0.00
Cytosorbents (CTSO) United States $0.178B 0.00
Vapotherm (VAPO) United States $0.174B 0.00
Chimerix (CMRX) United States $0.143B 0.00
Fonar (FONR) United States $0.142B 10.11
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Female Health (VERU) United States $0.122B 0.00
United-Guardian (UG) United States $0.085B 20.07
Nephros (NEPH) United States $0.068B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.027B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00